Table 1.
Baseline characteristics, baseline and final BCVA, and CST
| Parameter | |
|---|---|
| Eyes/patients | 36/36 |
| Age (years) | 62.1 ± 9.3 (44-85 years) |
| Men/women | 19/17 |
| HbA1c (%) | 7.3 ± 0.4 (6.6-8.0) |
| Systemic hypertension (no. of patients) | 17 |
| LogMAR VA | 0.55 ± 0.28 (1.0-0.0) |
| Moderate nonproliferative DRP | 12 eyes (33.3%) |
| Severe nonproliferative DRP | 14 eyes (38.9%) |
| Proliferative DRP | 10 eyes (27.8%) |
| Pseudophakia (%) | 12 eyes (33.3%) |
| CSF thickness (µm) | 494.7 ± 152.1 |
| Hyperreflective foci in the inner retinal layers | 24 eyes (66.6%) |
| Hperreflective foci in the outer retinal layers | 17 eyes (47.2%) |
| Subretinal fluid | 11 eyes (30.5%) |
| DRIL | 18 eyes (50.0%) |
| Disrupted EZ line | 16 eyes (44.4%) |
| Total cyst area | 10946.5 ± 4014.6 |
| Cystoid spaces in the outer retinal layers | 21 eyes (58.3%) |
| Mean intracystic reflectance | 43.3 ± 7.5 |
BCVA= best-corrected visual acuity; CST= central subfield thickness; DRP; DRIL= disorganization of retinal inner layers; EZ= ellipsoid zone; HbA1c= hemoglobin A1C.